Who does it
Rainer Henning, PhD (Chief Executive Officer)
combines extensive experience in both the pharmaceutical and biotech industries with a professional background as investment manager. Concomitant to his service at Virvaxx he is also CEO of our parent company Biomay. Prior to joining Biomay and Viravaxx he successfully served as CEO of Fibrex Medical Inc. At Hoechst AG (now part of Sanofi Aventis) he held several positions including Deputy Head of Cardiovascular Research and was Managing Director of Nippon Hoechst Marion Roussel. He co-invented the blockbuster antihypertensives Tritace® and Odrik® and authored well over 80 granted patents. At Future Capital and Brilleon Capital he served as investment manager and partner.
Karl Fister (Chief Financial Officer)
is Managing Partner of Selca Beteiligungs GmbH, a company successfully investing in industrial and high-tech enterprises and major shareholder in Viravaxx. Prior to his career in investment management he was heading a chain of food supply stores.